Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00307
|
|||||
Drug Name |
Berberine
|
|||||
Synonyms |
0I8Y3P32UF; 2086-83-1; 7,8,13,13a-tetradehydro-9,10-dimethoxy-2,3-(methylenedioxy)berbinium; 9,10-Dimethoxy-2,3-(methylenedioxy)-7,8,13,13a-tetrahydroberbinium; 9,10-dimethoxy-5,6-dihydro[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ium; BERBINIUM, 7,8,13,13a-TETRAHYDRO-9,10-DIMETHOXY-2,3-(METHYLE; BRN 3570374; Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium, 5,6-dihydro-9,10-dimethoxy-; Berbamine sulphate acid; Berberal; Berberin; CHEBI:16118; CHEMBL12089; EINECS 218-229-1; ST055798; UNII-0I8Y3P32UF; Umbellatine
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Diabetes [ICD11: 5A10-5A14] | Phase 4 | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C20H18NO4+
|
|||||
Canonical SMILES |
COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC
|
|||||
InChI |
InChI=1S/C20H18NO4/c1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2/h3-4,7-10H,5-6,11H2,1-2H3/q+1
|
|||||
InChIKey |
YBHILYKTIRIUTE-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 2086-83-1
|
|||||
Pharmaceutical Properties | Molecular Weight | 336.4 | Topological Polar Surface Area | 40.8 | ||
Heavy Atom Count | 25 | Rotatable Bond Count | 2 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 4 | |||
XLogP |
3.6
|
|||||
PubChem CID | ||||||
PubChem SID |
10513274
, 11112431
, 11335440
, 11360679
, 11364004
, 11366566
, 11369128
, 11371756
, 11374369
, 11377290
, 11405445
, 11405619
, 11408710
, 11447002
, 11461651
, 11466614
, 11467734
, 11484444
, 11486387
, 11488710
, 11490434
, 11492600
, 11494924
, 11537739
, 12146010
, 14777746
, 22390066
, 22391440
, 26753128
, 29221521
, 33889979
, 4019
, 46487939
, 46506051
, 47365076
, 47515214
, 47515215
, 47515216
, 47662167
, 47736364
, 47810644
, 5424490
, 5424491
, 5609012
, 598412
, 7886143
, 7927271
, 8145003
, 8151578
, 841172
|
|||||
ChEBI ID |
ChEBI:16118
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | OCT-1 | Transporter Info | Organic cation transporter 1 | Substrate | [2] | |
P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [3] | ||
References | ||||||
1 | ClinicalTrials.gov (NCT03029390) Effect of Berberine Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes | |||||
2 | Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1). Naunyn Schmiedebergs Arch Pharmacol. 2008 Feb;376(6):449-61. | |||||
3 | P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers. J Pharm Sci. 2002 Dec;91(12):2614-21. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.